Arcutis to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024

Group 1 - Arcutis Biotherapeutics, Inc. will report its first quarter 2024 financial results and provide a business update on May 14, 2024, after U.S. financial markets close [1] - A conference call and webcast will be held on the same day at 4:30 p.m. ET, with a live webcast available on the company's website [1] - An archived replay of the webcast will be accessible on the Arcutis investor website following the conference call [1] Group 2 - Arcutis Biotherapeutics is a commercial-stage medical dermatology company focused on innovations for immune-mediated dermatological diseases [2] - The company has two FDA-approved products and a growing portfolio that addresses persistent patient challenges in dermatology [2] - Arcutis' development platform includes a robust pipeline with multiple clinical programs targeting inflammatory dermatological conditions such as scalp and body psoriasis, atopic dermatitis, and alopecia areata [2]